ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association …
Writing Committee Members, AE Epstein, JP DiMarco… - Circulation, 2008 - Am Heart Assoc
This revision of the “ACC/AHA/NASPE Guidelines for Implantation of Cardiac Pacemakers
and Antiarrhythmia Devices” updates the previous versions published in 1984, 1991, 1998 …
and Antiarrhythmia Devices” updates the previous versions published in 1984, 1991, 1998 …
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College …
Developed in Collaboration With the European … - Journal of the American …, 2006 - jacc.org
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and
the Prevention of Sudden Cardiac Death: A Report of the American College of …
the Prevention of Sudden Cardiac Death: A Report of the American College of …
2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the …
AE Epstein, JP DiMarco, KA Ellenbogen… - Circulation, 2013 - Am Heart Assoc
The online-only Data Supplement is available with this article at http://circ. ahajournals.
org/lookup/suppl/doi: 10.1161/CIR. 0b013e318276ce9b/-/DC1. The online-only …
org/lookup/suppl/doi: 10.1161/CIR. 0b013e318276ce9b/-/DC1. The online-only …
Implantable cardioverter-defibrillators: expanding indications and technologies
Z Goldberger, R Lampert - Jama, 2006 - jamanetwork.com
ContextSudden cardiac death (SCD) is a major challenge facing contemporary cardiology.
For an increasing number of patients, the current standard of care for the treatment and …
For an increasing number of patients, the current standard of care for the treatment and …
Asymptomatic or “silent” atrial fibrillation: frequency in untreated patients and patients receiving azimilide
RL Page, TW Tilsch, SJ Connolly, DJ Schnell… - Circulation, 2003 - Am Heart Assoc
Background—Asymptomatic, or “silent” atrial fibrillation could increase the risk of stroke.
Little is known about the frequency of asymptomatic atrial fibrillation in patients who also …
Little is known about the frequency of asymptomatic atrial fibrillation in patients who also …
The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency: results of a randomized trial in patients with bradycardia and atrial …
MA Lee, R Weachter, S Pollak, MS Kremers… - Journal of the American …, 2003 - jacc.org
Abstract Objectives: The Atrial Therapy Efficacy and Safety Trial (ATTEST) was a
prospective, randomized study to evaluate preventive pacing and antitachycardia pacing …
prospective, randomized study to evaluate preventive pacing and antitachycardia pacing …
Accuracy of atrial tachyarrhythmia detection in implantable devices with arrhythmia therapies
H Purerfellner, AM Gillis, R Holbrook… - Pacing and Clinical …, 2004 - Wiley Online Library
The clinical application of atrial tachyarrhythmia (AT) episode data stored by implantable
devices is presently limited by the high proportion of inappropriate detection. We quantified …
devices is presently limited by the high proportion of inappropriate detection. We quantified …
Do atrial tachyarrhythmias beget ventricular tachyarrhythmias in defibrillator recipients?
KM Stein, DE Euler, R Mehra, K Seidl… - Journal of the American …, 2002 - jacc.org
Objectives: This study was designed to analyze the incidence of “dual tachycardia”—
ventricular tachycardia (VT) or ventricular fibrillation (VF) preceded by paroxysmal atrial …
ventricular tachycardia (VT) or ventricular fibrillation (VF) preceded by paroxysmal atrial …
Genetic mechanisms of atrial fibrillation: impact on response to treatment
Atrial fibrillation (AF) is the most-common sustained arrhythmia observed in clinical practice,
but response to therapy is highly variable between patients. Current drug therapies to …
but response to therapy is highly variable between patients. Current drug therapies to …